HIGH LOSS TO FOLLOW UP AMONG CHILDREN ON PRE-ART CARE UNDER NATIONAL AIDS PROGRAM IN MADURAI, SOUTH INDIA.

BACKGROUND Information on the follow-up of HIV-infected children enrolled into pre-antiretroviral therapy (Pre-ART) care under routine program settings is limited in India. Knowledge on the magnitude of loss to follow up (LFU) and its reasons will help programs to retain children in HIV care. We aimed to assess the proportion of LFU among children in Pre-ART care and its associated factors. METHODS In this retrospective cohort study, we reviewed the records of all HIV-infected children (aged <15 years) registered from 2005 to 2012 at an ART centre, Madurai, South India. LFU during pre-ART care was defined as having not visited the ART centre within a year of registration. RESULTS Of 426 children enrolled in Pre-ART care, 211 (49%) were females and 301 (71%) were in the 5-14 years age group. At one year of registration, 348 (82%) were lost to follow-up. Of 348, 81 returned to care after one year of enrolment while 267 (63% of all children) were permanently lost-to-follow-up. The proportion of LFU remained high from 2005 to 2012. WHO staging, CD4 count and OI were the significant factors associated with lost to follow-up on multivariate analysis. CONCLUSION LFU was alarmingly high indicating poor clinical and programmatic monitoring among HIV-infected children enrolled in pre-ART care. A system for active tracing of those missing a clinic appointment, intensified supervision and monitoring along with qualitative research is urgently needed. This will help to understand the exact reasons for LFU based on which effective interventions may be planned for reducing such losses.

[1]  W. Mcfarland,et al.  Factors Determining Survival and Retention among HIV-Infected Children and Adolescents in a Community Home-Based Care and a Facility-Based Family-Centred Approach in Kampala, Uganda: A Cohort Study , 2014, ISRN AIDS.

[2]  G. Alvarez-Uria,et al.  Predictors of loss to follow-up after engagement in care of HIV-infected children ineligible for antiretroviral therapy in an HIV cohort study in India. , 2014, Germs.

[3]  A. De Costa,et al.  Effectiveness of First-line Antiretroviral Therapy and Acquired Drug Resistance Among HIV-1–infected Children in India , 2013, The Pediatric infectious disease journal.

[4]  M. Egger,et al.  Retention in Care of HIV-Infected Children from HIV Test to Start of Antiretroviral Therapy: Systematic Review , 2013, PloS one.

[5]  A. Jaye,et al.  Mortality and loss to programme before antiretroviral therapy among HIV-infected children eligible for treatment in The Gambia, West Africa , 2012, AIDS Research and Therapy.

[6]  M. Sarkar,et al.  Food supplementation as an incentive to improve pre-antiretroviral therapy clinic adherence in HIV-positive children--experience from eastern India. , 2012, Journal of tropical pediatrics.

[7]  A. Dubey,et al.  Adherence to antiretroviral therapy and its correlates among HIV-infected children at an HIV clinic in New Delhi , 2011, Annals of tropical paediatrics.

[8]  G. Cooke,et al.  Retention in HIV Care for Individuals Not Yet Eligible for Antiretroviral Therapy: Rural KwaZulu-Natal, South Africa , 2011, Journal of acquired immune deficiency syndromes.

[9]  F. Dabis,et al.  Scaling up antiretroviral therapy for HIV-infected children in Côte d'Ivoire: determinants of survival and loss to programme. , 2010, Bulletin of the World Health Organization.

[10]  Nneka Emenyonu,et al.  Understanding Reasons for and Outcomes of Patients Lost to Follow-Up in Antiretroviral Therapy Programs in Africa Through a Sampling-Based Approach , 2010, Journal of acquired immune deficiency syndromes.

[11]  R. Zachariah,et al.  High survival and treatment success sustained after two and three years of first-line ART for children in Cambodia , 2010, Journal of the International AIDS Society.

[12]  Mardge H. Cohen,et al.  Association of hepatitis C virus and HIV infection with subclinical atherosclerosis in the women's interagency HIV study , 2009, AIDS.

[13]  R. Zachariah,et al.  Excellent outcomes among HIV+ children on ART, but unacceptably high pre-ART mortality and losses to follow-up: a cohort study from Cambodia , 2009, BMC pediatrics.

[14]  L. Jeyaseelan,et al.  Efficacy of antiretroviral therapy program in children in India: prognostic factors and survival analysis. , 2009, Journal of tropical pediatrics.

[15]  B. Stoll,et al.  Early assessment of the implementation of a national programme for the prevention of mother‐to‐child transmission of HIV in Cameroon and the effects of staff training: a survey in 70 rural health care facilities , 2009, Tropical medicine & international health : TM & IH.

[16]  R. Shenbagavalli,et al.  Rapid progression of HIV infection in infancy. , 2009, Indian pediatrics.

[17]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.

[18]  C. Duncombe,et al.  Guidelines on co-trimoxazole prophylaxis for HIV-related infections among children adolescents and adults. Recommendations for a public health approach. , 2006 .

[19]  Xiaonan Xue,et al.  Estimating the relative risk in cohort studies and clinical trials of common outcomes. , 2003, American journal of epidemiology.